Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Kidney involvement in patients with systemic lupus erythematosus—lupus nephritis (LN)—is
one of the most important and common clinical manifestations of this disease and occurs in …

Objective To update the 2012 EULAR/ERA–EDTA recommendations for the management of
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …

Fibrosis can be defined as a pathological process in which deposition of connective tissue
replaces normal parenchyma. The kidney, like any organ or tissue, can be impacted by this …

The glomerular crescent: triggers, evolution, resolution, an... : Current Opinion in Nephrology
and Hypertension The glomerular crescent: triggers, evolution, resolution, and implications for …

Systemic lupus erythematosus (SLE) is the prototype of autoimmune disorders caused by a
loss of tolerance to endogenous nuclear antigens triggering an aberrant autoimmune …

Systemic lupus erythematosus (SLE) is prevalent in Asia and carries a variable prognosis
among patients across the Asia-Pacific region, which could relate to access to health care …

The collaborative efforts of patients, clinical and translational researchers, the
pharmaceutical industry and funding sources are needed to advance therapies for lupus …

CD163 is a marker for alternatively activated macrophages, which have been implicated in
the pathogenesis of lupus nephritis (LN). In our preliminary screening of urine proteins in …

Chronic kidney disease (CKD) results in high morbidity and mortality worldwide causing a
huge socioeconomic burden. MicroRNA (miRNA) exert critical regulatory functions by …